To evaluate whetherthe TNG462 antitumor activitywas limited by tumor histology, we also profiled TNG462 in a panel of 22 MTAP-null patient-derived xenograft (PDX) modelsrepresenting tumor histologies that are frequently MTAP-deleted. The gene discussed is MTAP; the disease is neoplasm.